Sec Form 4 Filing - HEBERT MAURICE @ MOLINA HEALTHCARE, INC. - 2021-03-01

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
HEBERT MAURICE
2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Accounting Officer
(Last) (First) (Middle)
2180 HARVARD STREET, SUITE 400
3. Date of Earliest Transaction (MM/DD/YY)
03/01/2021
(Street)
SACRAMENTO, CA95815
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2021 A( 1 ) 900 A $ 222.24 ( 2 ) 4,036 D
Common Stock 03/01/2021 F( 3 ) 209 D $ 222.24 ( 2 ) 3,827 D
Common Stock 03/01/2021 A( 4 ) 2,026 A $ 222.24 ( 2 ) 5,853 D
Common Stock 03/01/2021 F( 5 ) 721 D $ 222.24 ( 2 ) 5,132 ( 6 ) ( 7 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
HEBERT MAURICE
2180 HARVARD STREET
SUITE 400
SACRAMENTO, CA95815
Chief Accounting Officer
Signatures
Jeff D. Barlow, by power of attorney for Maurice Hebert 03/03/2021
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.
( 2 )Represents the closing price of the Issuer's common stock on March 1, 2021.
( 3 )The shares were applied to the payment of withholding taxes arising in connection with the vesting of 603 shares on March 1, 2021.
( 4 )Shares issued in settlement of performance stock units granted in 2018 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2018, 2019, and 2020.
( 5 )Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.
( 6 )Shares shall vest as follows: the 900 newly granted shares vest in one-third increments on each of March 1, 2022, March 1, 2023, and March 1, 2024. Additional shares vest as follows: 603 shares on March 1, 2022; 602 shares on March 1, 2023; 331 shares on March 1, 2024; 253 shares on each of October 1, 2021 and October 1, 2022. The remainder of the shares are vested.
( 7 )The vesting period of the March 1, 2020 grant of 1,326 shares was corrected to reflect shares remaining subject to vesting. The vesting period was previously erroneously reported as a three-year vesting period rather than the actual four-year vesting period.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.